Observational retrospective study To characterize and assess clinical outcomes of patients Receiving tezepelumab in the framework Of use in Special Situations prior to commercialisation in Spain (T-ROSS).
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
Portal de investigación